{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:59:17Z","timestamp":1788829157208,"version":"build-2803163510"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bpg.2025.102056","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:48:06Z","timestamp":1760662086000},"page":"102056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Atherosclerotic cardiovascular disease and inflammatory bowel disease: epidemiology, pathogenesis and risk assessment"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0935-8853","authenticated-orcid":false,"given":"Pierluigi","family":"Puca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5788-4068","authenticated-orcid":false,"given":"Simone","family":"Parello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Colantuono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Scaldaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bpg.2025.102056_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","article-title":"Global trends in atherosclerotic cardiovascular disease","volume":"45","author":"Nedkoff","year":"2023","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.bpg.2025.102056_bib4","first-page":"1204","article-title":"Epidemiology of elderly onset IBD: a nationwide population-based cohort study","volume":"23","author":"Singh","year":"2025","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"12","key":"10.1016\/j.bpg.2025.102056_bib5","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1161\/ATVBAHA.124.319983","article-title":"Immune-mediated inflammatory diseases, dyslipidemia, and cardiovascular risk: a complex interplay","volume":"44","author":"Wilkinson","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10354","key":"10.1016\/j.bpg.2025.102056_bib6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet Lond Engl"},{"issue":"7","key":"10.1016\/j.bpg.2025.102056_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.bpg.2025.102056_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015","article-title":"Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study","volume":"67","author":"Kirchgesner","year":"2018","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib9","first-page":"761","article-title":"Inflammatory bowel disease is associated with an increased risk of incident acute arterial events: analysis of the United Kingdom biobank","volume":"21","author":"Alayo","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib10","first-page":"961","article-title":"Risk of major adverse cardiovascular events in immune-mediated inflammatory disorders on biologics and small molecules: network meta-analysis","volume":"22","author":"Mattay","year":"2024","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"issue":"9715","key":"10.1016\/j.bpg.2025.102056_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.bpg.2025.102056_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib14","first-page":"680","article-title":"The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"34","author":"Arvanitakis","year":"2021","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"10.1016\/j.bpg.2025.102056_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study","volume":"8","author":"Kristensen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2025.102056_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2023.02.042","article-title":"Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: a systematic review with meta-analysis","volume":"378","author":"D'Ascenzo","year":"2023","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.bpg.2025.102056_bib17","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.08.008","article-title":"Risk of stroke in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"24","author":"Xiao","year":"2015","journal-title":"J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc"},{"issue":"15","key":"10.1016\/j.bpg.2025.102056_bib18","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis","volume":"25","author":"Sun","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.bpg.2025.102056_bib19","first-page":"119","article-title":"Association between chronic immune-mediated inflammatory diseases and cardiovascular risk","volume":"104","author":"Baena-D\u00edez","year":"2018","journal-title":"Heart Br Card Soc"},{"issue":"2","key":"10.1016\/j.bpg.2025.102056_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/a-1283-6966","article-title":"Increased risk of ischemic heart disease and diabetes in inflammatory bowel disease","volume":"59","author":"Li","year":"2021","journal-title":"Z Gastroenterol"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.amjmed.2021.02.029","article-title":"Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease","volume":"134","author":"Lee","year":"2021","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.bpg.2025.102056_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2159","article-title":"Increased risk of stroke among patients with inflammatory bowel disease: a PRISMA-compliant meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.bpg.2025.102056_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100316","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey","volume":"9","author":"Nasir","year":"2022","journal-title":"Am J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib24","first-page":"547","article-title":"Vascular complications in hospitalized patients with inflammatory bowel disease and acute gastroenteritis and colitis: a propensity score-matched study","volume":"57","author":"Papa","year":"2025","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ecco-jcc\/jjy164","article-title":"Cardiovascular risk profile among patients with inflammatory bowel disease: a population-based study of more than 100 000 individuals","volume":"13","author":"Aarestrup","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2025.102056_bib27","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/MIB.0000000000000109","article-title":"Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease","volume":"20","author":"Aggarwal","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib28","first-page":"382","article-title":"Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"12","author":"Singh","year":"2014","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib29","first-page":"41","article-title":"The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study","volume":"6","author":"Bernstein","year":"2008","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005892","article-title":"Inflammatory bowel disease and risk of ischemic heart disease: an updated meta-analysis of cohort studies","volume":"6","author":"Feng","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.crohns.2010.09.008","article-title":"Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease","volume":"5","author":"Haapam\u00e4ki","year":"2011","journal-title":"J Crohns Colitis"},{"issue":"17","key":"10.1016\/j.bpg.2025.102056_bib32","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2009.04.098","article-title":"Women and ischemic heart disease: evolving knowledge","volume":"54","author":"Shaw","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?","volume":"30","author":"Bigeh","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.bpg.2025.102056_bib34","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","article-title":"Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis","volume":"34","author":"Messner","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.bpg.2025.102056_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002483","article-title":"Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysis","volume":"10","author":"Zaka","year":"2023","journal-title":"Open Heart"},{"issue":"6","key":"10.1016\/j.bpg.2025.102056_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","article-title":"Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies","volume":"8","author":"Fumery","year":"2014","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.amjsurg.2014.08.026","article-title":"Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population","volume":"210","author":"Tsai","year":"2015","journal-title":"Am J Surg"},{"issue":"21 Suppl 1","key":"10.1016\/j.bpg.2025.102056_bib39","first-page":"II2","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"Willerson","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bpg.2025.102056_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41575-021-00492-8","article-title":"International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease","volume":"18","author":"Olivera","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2025.102056_bib41","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ajg.2009.81","article-title":"Risk of arterial thrombotic events in inflammatory bowel disease","volume":"104","author":"Ha","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib42","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/gutjnl-2012-303285","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study","volume":"62","author":"Rungoe","year":"2013","journal-title":"Gut"},{"issue":"52","key":"10.1016\/j.bpg.2025.102056_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002381","article-title":"Inflammatory bowel disease increases the risk of peripheral arterial disease: a nationwide cohort study","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/ibd\/izac100","article-title":"Lipid changes after induction therapy in patients with inflammatory bowel disease: effect of different drug classes and inflammation","volume":"29","author":"Sleutjes","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.102056_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.thromres.2023.11.005","article-title":"Gut dysbiosis-related thrombosis in inflammatory bowel disease: potential disease mechanisms and emerging therapeutic strategies","volume":"232","author":"Papa","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.bpg.2025.102056_bib46","article-title":"Innovative, complementary and alternative therapy in inflammatory bowel diseases: a broad 2020s update","volume":"1","author":"Masi","year":"2022","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib47","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/ibd\/izae120","article-title":"Mortality of patients with inflammatory bowel disease in the Faroe Islands from 1966-2020","volume":"31","author":"Nielsen","year":"2025","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib48","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ibd.21187","article-title":"Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study","volume":"16","author":"Andersohn","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.bpg.2025.102056_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139745","article-title":"Risk of ischaemic heart disease in patients with inflammatory bowel disease: Cohort study using the general practice research database","volume":"10","author":"Close","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ajg.2017.479","article-title":"Increased mortality rates with prolonged corticosteroid therapy when compared with antitumor necrosis Factor-\u03b1-Directed therapy for inflammatory bowel disease","volume":"113","author":"Lewis","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"suppl_1","key":"10.1016\/j.bpg.2025.102056_bib51","doi-asserted-by":"crossref","first-page":"S305","DOI":"10.1093\/ecco-jcc\/jjx002.573","article-title":"P448 biologic therapy and immunodulators are associated with decreased risk of cardiovascular events in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"11","author":"Fumery","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib52","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gutjnl-2019-318932","article-title":"Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study","volume":"69","author":"Kirchgesner","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib53","first-page":"164","article-title":"Risk of recurrent acute arterial events associated with thiopurines and anti-tumor necrosis factor in inflammatory bowel diseases","volume":"21","author":"Dheyriat","year":"2023","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.bpg.2025.102056_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cyto.2018.03.041","article-title":"The regulation of JAKs in cytokine signaling and its breakdown in disease","volume":"118","author":"Hammar\u00e9n","year":"2019","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.bpg.2025.102056_bib55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/biom10071002","article-title":"JAK-Inhibitors for the treatment of rheumatoid arthritis: a focus on the present and an outlook on the future","volume":"10","author":"Angelini","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib56","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3324\/haematol.2013.100016","article-title":"Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia","volume":"99","author":"Grisouard","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(00)81168-X","article-title":"Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis","volume":"93","author":"Neubauer","year":"1998","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib58","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3390\/ijms22052449","article-title":"Thromboembolic adverse drug reactions in Janus Kinase (JAK) inhibitors: does the inhibitor specificity play a role?","volume":"22","author":"Kotyla","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.bpg.2025.102056_bib59","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1136\/gutjnl-2019-318448","article-title":"JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?","volume":"68","author":"Danese","year":"2019","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40264-017-0622-2","article-title":"Analysis of spontaneous postmarket case reports submitted to the FDA regarding thromboembolic adverse events and JAK inhibitors","volume":"41","author":"Verden","year":"2018","journal-title":"Drug Saf"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib61","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2018-214846","article-title":"Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials","volume":"78","author":"Xie","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpg.2025.102056_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19895492","article-title":"Effect of tofacitinib on cardiovascular events and all-cause mortality in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Xie","year":"2019","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.bpg.2025.102056_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1586792","article-title":"Efficacy and safety of upadacitinib for patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis","volume":"16","author":"Chai","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.bpg.2025.102056_bib64","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1053\/j.gastro.2020.01.001","article-title":"Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: a systematic review and meta-analysis","volume":"158","author":"Olivera","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2025.102056_bib65","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/ecco-jcc\/jjad104","article-title":"Major adverse cardiovascular events by baseline cardiovascular risk in patients with ulcerative colitis treated with tofacitinib: data from the OCTAVE clinical programme","volume":"17","author":"Schreiber","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"11","key":"10.1016\/j.bpg.2025.102056_bib66","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/annrheumdis-2019-216761","article-title":"Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data","volume":"79","author":"Mease","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.bpg.2025.102056_bib67","first-page":"S1542","article-title":"Comparative safety of janus kinase inhibitors vs. tumor necrosis factor antagonists in patients with inflammatory bowel diseases","author":"Ahuja","year":"2025","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib68","first-page":"123","article-title":"Tofacitinib treatment is associated with modest and reversible increases in serum lipids in patients with ulcerative colitis","volume":"18","author":"Sands","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.bpg.2025.102056_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1366192","article-title":"An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients","volume":"14","author":"Scanu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bpg.2025.102056_bib70","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-335610","article-title":"Gut microbiota and atherosclerosis","author":"Fusco","year":"2025","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.bpg.2025.102056_bib71","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","article-title":"Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis","volume":"64","author":"Tang","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.bpg.2025.102056_bib72","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/ATVBAHA.118.311023","article-title":"Gut microbiota-dependent trimethylamine N-Oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes","volume":"38","author":"Haghikia","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1016\/j.bpg.2025.102056_bib73","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.122.060573","article-title":"Gut microbiota-derived trimethylamine N-Oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms","volume":"147","author":"Benson","year":"2023","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bpg.2025.102056_bib74","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jchf.2023.03.008","article-title":"Microbially produced imidazole propionate is associated with heart failure and mortality","volume":"11","author":"Molinaro","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib75","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/ATVBAHA.124.322346","article-title":"Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis","volume":"45","author":"Nageswaran","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"10.1016\/j.bpg.2025.102056_bib76","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3390\/nu14132664","article-title":"Bile acid-related regulation of mucosal inflammation and intestinal motility: from pathogenesis to therapeutic application in IBD and microscopic colitis","volume":"14","author":"Di Vincenzo","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib77","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ajcnut.2024.02.019","article-title":"Changes in bile acid subtypes and improvements in lipid metabolism and atherosclerotic cardiovascular disease risk: the preventing overweight using novel dietary strategies (POUNDS lost) trial","volume":"119","author":"Heianza","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.bpg.2025.102056_bib78","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1007\/s10620-023-08122-w","article-title":"Intestinal barrier dysfunction in inflammatory bowel disease: underpinning pathogenesis and therapeutics","volume":"68","author":"Dunleavy","year":"2023","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib80","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ibd.20019","article-title":"Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease","volume":"13","author":"Pastor Rojo","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12959-023-00514-2","article-title":"Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice","volume":"21","author":"Liu","year":"2023","journal-title":"Thromb J"},{"issue":"18","key":"10.1016\/j.bpg.2025.102056_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810900","article-title":"The controversial role of LPS in platelet activation in vitro","volume":"23","author":"Galgano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpg.2025.102056_bib83","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3389\/fimmu.2020.00705","article-title":"Platelet toll-like receptors mediate thromboinflammatory responses in patients with essential thrombocythemia","volume":"11","author":"Mar\u00edn Oyarz\u00fan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102056_bib84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.thromres.2021.11.019","article-title":"Toll-like receptor 4 activation in platelets from myocardial infarction patients","volume":"209","author":"Barill\u00e0","year":"2022","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.bpg.2025.102056_bib85","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.122.321541","article-title":"Toll-Like receptor 4-Dependent platelet-related thrombosis in SARS-CoV-2 infection","volume":"132","author":"Carnevale","year":"2023","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.bpg.2025.102056_bib86","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3892\/etm.2015.2370","article-title":"Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1\u03b2, interleukin-2 and interleukin-17","volume":"9","author":"Kleiner","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bpg.2025.102056_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310086","article-title":"Circulating levels of cytokines and risk of inflammatory bowel disease: evidence from genetic data","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"40","key":"10.1016\/j.bpg.2025.102056_bib88","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.3748\/wjg.v27.i40.6757","article-title":"Venous and arterial thromboembolism in patients with inflammatory bowel diseases","volume":"27","author":"Stadnicki","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2025.102056_bib89","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/heart.89.9.993","article-title":"Inflammatory and thrombotic mechanisms in coronary atherosclerosis","volume":"89","author":"Tousoulis","year":"2003","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.bpg.2025.102056_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187189","article-title":"Interaction of IL-6 and TNF-\u03b1 contributes to endothelial dysfunction in type 2 diabetic mouse hearts","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib91","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ibd.20896","article-title":"Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation","volume":"15","author":"Yoshida","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"10.1016\/j.bpg.2025.102056_bib92","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/cells14100738","article-title":"Neutrophils at the crossroads of inflammatory bowel disease and atherosclerosis: a state-of-the-art review","volume":"14","author":"Genkel","year":"2025","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.bpg.2025.102056_bib93","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.5551\/jat.63887","article-title":"Distinct WBC trajectories are associated with the risks of incident CVD and all-cause mortality","volume":"30","author":"Yang","year":"2023","journal-title":"J Atherosclerosis Thromb"},{"issue":"Supplement_2","key":"10.1016\/j.bpg.2025.102056_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac544.3042","article-title":"Neutrophils as major drivers of increased atherosclerosis in a murine model of chronic colitis","volume":"43","author":"Ostendorf","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.bpg.2025.102056_bib95","article-title":"Analysis of the molecular mechanisms of ulcerative colitis and atherosclerosis by microarray data","volume":"15","author":"Wu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2025.102056_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.896645","article-title":"Neutrophil infiltration characterized by upregulation of S100A8, S100A9, S100A12 and CXCR2 is associated with the Co-Occurrence of Crohn's disease and peripheral artery disease","volume":"13","author":"Yao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpg.2025.102056_bib97","article-title":"Bridging inflammation and venous thrombosis: the NLRP3 inflammasome connection","volume":"12","author":"Wu","year":"2025","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.bpg.2025.102056_bib98","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvab010","article-title":"NLRP3 inflammasome as a key driver of vascular disease","volume":"118","author":"Takahashi","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"23","key":"10.1016\/j.bpg.2025.102056_bib99","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.3390\/cells12232709","article-title":"NLRP3-Induced NETosis: a potential therapeutic target for ischemic thrombotic diseases?","volume":"12","author":"Kumar","year":"2023","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.bpg.2025.102056_bib100","first-page":"5284","article-title":"MicroRNA-19b alleviates lipopolysaccharide-induced inflammatory injury in human intestinal cells by up-regulation of Runx3","volume":"22","author":"Qiao","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7293","key":"10.1016\/j.bpg.2025.102056_bib101","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2025.102056_bib102","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3464042","article-title":"Magnetic resonance images, pathological features of thrombus, and expression of NLRP inflammasome in patients with acute ischemic stroke","volume":"2022","author":"Wang","year":"2022","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.bpg.2025.102056_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108967","article-title":"Hirudin alleviates acute ischemic stroke by inhibiting NLRP3 inflammasome-mediated neuroinflammation: in vivo and in vitro approaches","volume":"110","author":"Li","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib104","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/STROKEAHA.118.023620","article-title":"Extent of ischemic brain injury after thrombotic stroke is independent of the NLRP3 (NACHT, LRR and PYD domains-containing protein 3) inflammasome","volume":"50","author":"Lemarchand","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib105","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1007\/s12325-025-03154-2","article-title":"Management of atherosclerotic cardiovascular risk in inflammatory bowel disease: current perspectives","volume":"42","author":"Masson","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.bpg.2025.102056_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211032126","article-title":"Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management","volume":"14","author":"Sleutjes","year":"2021","journal-title":"Ther Adv Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib107","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0003319716652031","article-title":"Subclinical atherosclerosis in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"68","author":"Wu","year":"2017","journal-title":"Angiology"},{"issue":"9","key":"10.1016\/j.bpg.2025.102056_bib108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2036.2005.02657.x","article-title":"Increased carotid intima-media thickness in patients with inflammatory bowel disease","volume":"22","author":"Papa","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib109","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/0003319720918509","article-title":"Aortic stiffening is an extraintestinal manifestation of inflammatory bowel disease: review of the literature and expert Panel statement","volume":"71","author":"Zanoli","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.bpg.2025.102056_bib110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2023.08.011","article-title":"Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease","volume":"266","author":"Naami","year":"2023","journal-title":"Am Heart J"},{"issue":"25 Suppl 2","key":"10.1016\/j.bpg.2025.102056_bib111","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/american heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.bpg.2025.102056_bib112","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.bpg.2025.102056_bib113","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease: JACC review topic of the week","volume":"76","author":"Cainzos-Achirica","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.bpg.2025.102056_bib114","article-title":"Spanish working group in Crohn's disease and ulcerative colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease","volume":"48","author":"Mar\u00edn-Jim\u00e9nez","year":"2025","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.bpg.2025.102056_bib115","first-page":"204","article-title":"Cardiovascular comorbidities and inflammatory bowel disease: causes and consequences","volume":"20","author":"Sinh","year":"2024","journal-title":"Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2025.102056_bib116","first-page":"1270","article-title":"Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus","volume":"56","author":"Olivera","year":"2024","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:19:22Z","timestamp":1764793162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691825000836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":116,"alternative-id":["S1521691825000836"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102056","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherosclerotic cardiovascular disease and inflammatory bowel disease: epidemiology, pathogenesis and risk assessment","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2025.102056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102056"}}